Intensity Therapeutics, Inc. (INTS)

Intensity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	11.92	2.59	8.56	1.31	4.54
Short-Term Investments	-	-	6.22	-	-
Cash & Short-Term Investments	11.92	2.59	14.78	1.31	4.54
Cash Growth	360.27%	-82.47%	1026.22%	-71.10%	-51.28%
Other Current Assets	0.79	0.77	0.69	0.14	0.19
Total Current Assets	12.71	3.36	15.46	1.45	4.73
Net Property, Plant & Equipment	0.1	0.12	0.15	0.14	0.32
Other Long-Term Assets	1.3	1.3	1.68	0.17	0.17
Total Assets	14.1	4.78	17.3	1.76	5.22
Accounts Payable	0.58	1.22	3.05	0.6	0.17
Accrued Expenses	1.53	0.51	0.89	1.72	1.35
Current Portion of Leases	0.03	0.03	0.02	0.14	0.18
Other Current Liabilities	-	-	-	4.35	2.02
Total Current Liabilities	2.15	1.76	3.96	6.82	3.72
Long-Term Leases	0.08	0.11	0.14	-	0.14
Other Long-Term Liabilities	-	-	0.04	0.04	0.04
Total Long-Term Liabilities	0.08	0.11	0.17	0.04	0.18
Total Liabilities	2.23	1.87	4.13	6.86	3.9
Preferred Stock	-	-	-	-	0
Common Stock	-	-	0	-	0
Additional Paid-in Capital	90.27	69.7	63.68	23.56	22.39
Retained Earnings	-78.39	-66.78	-50.52	-38.65	-31.07
Total Common Shareholders' Equity	11.88	2.92	13.16	-15.1	-8.68
Minority Interest	-	-	-	10	10
Shareholders' Equity	11.88	2.92	13.16	-5.1	1.32
Total Liabilities & Equity	14.1	4.78	17.3	1.76	5.22
Total Debt	0.11	0.14	0.16	0.14	0.33
Net Cash (Debt)	11.81	2.45	14.62	1.17	4.21
Net Cash Growth	381.69%	-83.23%	1150.47%	-72.25%	-52.22%
Net Cash Per Share	8.71	4.41	42.41	8.57	30.89
Book Value	11.88	2.92	13.16	-15.1	-8.68
Book Value Per Share	8.76	5.25	38.19	-110.69	-63.66
Tangible Book Value	11.88	2.92	13.16	-15.1	-8.68
Tangible Book Value Per Share	8.76	5.25	38.19	-110.69	-63.66

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q